NEONATAL SEPSIS

Clinical trials for NEONATAL SEPSIS explained in plain language.

Never miss a new study

Get alerted when new NEONATAL SEPSIS trials appear

Sign up with your email to follow new studies for NEONATAL SEPSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

Could a common antioxidant help save newborns from sepsis?

Disease control Not yet recruiting

This study tests whether adding N-acetylcysteine (NAC) to standard care improves outcomes in newborns with sepsis. Sepsis causes dangerous inflammation and cell damage, partly due to oxidative stress. NAC may reduce that damage. The trial will enroll 50 near-term and term infants…

Matched conditions: NEONATAL SEPSIS

Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

NEONATAL SEPSIS

Get alerted when new NEONATAL SEPSIS trials appear

Could a common antioxidant help save newborns from sepsis?